United Therapeutics Corp (UTHR)

Precedente Chiudi:

$262.40

Aprire:

$263.63

Volume 24 ore:

303.37K

Capitalizzazione di mercato:

$11.47B

Reddito:

$2.33B

Utile/perdita netta:

$984.80M

Rapporto P/E:

14.32

EPS:

18.15

Flusso di cassa netto:

$747.60M

1 W Prestazione:

+9.14%

1M Prestazione:

+11.34%

6M Prestazione:

+13.96%

1 anno Prestazione:

+21.45%

Intervallo 1D:

$256.08

$264.85

Portata 52W:

$204.44

$264.85

United Therapeutics Corp Stock (UTHR) Company Profile

Nome

United Therapeutics Corp

Settore

Healthcare (1223)

Industria

Biotechnology (699)

Telefono

301-608-9292

Indirizzo

1040 Spring Street, Silver Spring, MD

Dipendente

800

Cinguettio

Prossima data di guadagno

2024-05-01

Ultimi documenti SEC

UTHR's Discussions on Twitter

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-12	Aggiornamento	Goldman	Sell → Neutral
2024-02-05	Iniziato	Leerink Partners	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2022-12-06	Iniziato	UBS	Buy
2022-12-05	Iniziato	Goldman	Sell
2022-10-11	Iniziato	Morgan Stanley	Overweight
2022-09-20	Reiterato	BofA Securities	Underperform
2022-09-19	Ripresa	Wedbush	Outperform
2022-02-11	Iniziato	BTIG Research	Neutral
2021-07-14	Aggiornamento	Argus	Hold → Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-02-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-06-25	Reiterato	H.C. Wainwright	Neutral
2020-03-10	Aggiornamento	Jefferies	Hold → Buy
2020-02-27	Aggiornamento	Cowen	Market Perform → Outperform
2020-01-31	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-03	Iniziato	BofA/Merrill	Underperform
2019-08-01	Aggiornamento	Jefferies	Underperform → Hold
2019-08-01	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-05-17	Aggiornamento	UBS	Sell → Neutral
2019-05-09	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-12	Aggiornamento	Standpoint Research	Hold → Buy
2018-08-08	Downgrade	Credit Suisse	Neutral → Underperform
2018-04-03	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-02-22	Reiterato	Barclays	Underweight
2018-01-18	Ripresa	Credit Suisse	Underperform
2017-12-27	Reiterato	Wedbush	Outperform
2017-04-27	Reiterato	Wedbush	Outperform
2017-03-30	Iniziato	UBS	Sell
2017-03-16	Iniziato	Credit Suisse	Underperform

Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Zacks Investment Research

United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?

Zacks Investment Research

United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales

Zacks Investment Research

The Latest Analyst Ratings For United Therapeutics

Benzinga

Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics

Zacks Investment Research

What Makes United Therapeutics (UTHR) a New Buy Stock

Zacks Investment Research

United Therapeutics Corp Azioni (UTHR) Dati Finanziari

United Therapeutics Corp (UTHR) Reddito 2024

United Therapeutics Corp (UTHR) Reddito netto 2024

United Therapeutics Corp (UTHR) Flusso di cassa 2024

United Therapeutics Corp (UTHR) Utile per azione 2024

United Therapeutics Corp Azioni (UTHR) insider trading